The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

About The Agent Z Project

The Agent Z Project generates intellectual property which is then a commodity that can be sold , in part or in its entirety. That IP would relate to identifying infectious triggers of autoimmune diseases such as Multiple Sclerosis, Juvenile Diabetes and Inflammatory Bowel Disease. Identification would then lead to treatment and prevention via vaccination. This could help millions of affected and at-risk individuals and their loving families.

The Agent Z Project Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing The Agent Z Project

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

The Agent Z Project is included in 1 Expert Collection, including Diabetes.



1,750 items

Latest The Agent Z Project News

Pediatrician Edging Closer to Curing Multiple Sclerosis

Jul 20, 2015

Grass roots medical research launched to cure Multiple Sclerosis. Evidence points towards an environmental organism, and the Agent Z Project believes they know what it is and hopes to prove it. "We are focused on working the maze backwards. By doing this, we can meet conventional research in the middle, thus solving this problem. " - Chris Ostrowski (PRWEB)July 20, 2015 Spring Lake, Michigan: Dr. Michael Warmoth created the Agent Z Project as a lifelong dream to rid the world of Multiple Sclerosis. Multiple Sclerosis, or M.S. , is a deteriorating neurologic disease which afflicts those in the prime of their lives. This disease affects 300,000 people in the United States and 3.5 million worldwide. Sometimes it is progressive; other times it cruelly waxes and wanes. No cause has been identified thus far. The Agent Z team believes they have identified an environmental organism that may trigger M.S. , which they refer to as Agent Z. Dr. Warmoth and his Agent Z team believe they know the switch to turn off M.S. The Agent Z Project represents an alternate approach to standard drug discovery. Existing models attempt to minimize ongoing damage to the body. The cost of this approach runs an average of $75,000 per patient annually and the results can be mixed. Conclusively identifying the Agent Z organism would allow for vaccination to prevent the disease or prevent relapses in many cases. The cost would likely be much less. With sufficient funding, the team plans to test a vaccine against Agent Z in mice that are prone to develop M.S. The hope is that the vaccine will allow the mice to fight off the trigger and hence not develop the disease or relapse. Positive results would then allow partnerships with biotechnology firms skilled at further vaccine development. This approach could be a watershed moment for other diseases as well. The discovery of one autoimmune cure could lead to many others. Agent Z has evidentiary links to Type I Diabetes, Crohn’s Disease, Childhood Leukemia, and Juvenile Rheumatoid Arthritis. Engage in the solution and change the pace of cure development by clicking here: Agent Z How2Help-

    Discover the right solution for your team

    The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

    Request a demo

    CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.